Why the study?
Does pravastatin 40 mg daily reduce the progression of ischemic brain lesions?
Does pravastatin 40 mg daily reduce the progression of ischemic brain lesions?
Pravastatin 40 mg daily does not reduce the progression of ischemic brain lesions compared to placebo over a mean of 33 months.
No takes yet. Share an insight, caveat, or question.
Pravastatin offers no benefit against ischemic lesion progression; confirms neutral effect on this MRI surrogate in an RCT.
Dam et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: